Literature DB >> 18192105

Primary adult-onset macrophage activation syndrome with multisystemic tissue phagocytosis.

Anastasios Andreopoulos1, Xanthi Yiakoumis, Tilemachos-Christos Antoniou, George Andreopoulos, Konstantinos Konstantopoulos, Gerassimos A Pangalis, George Vaiopoulos.   

Abstract

The histiocyte disorders are divided into the following 3 categories according to the specific lineage of the histiocytes involved and their biological behavior: the dendritic cell-related disorders, which include Langerhans cell histiocytosis and dermal dendrocyte disorders; the macrophage cell disorders, hemophagocytic lymphohistiocytosis being the main entity; and the malignant histiocyte disorders. We present a case of a 36-year-old woman who was referred to our hospital because of fever of unknown origin, lethargy, anemia, and impaired hepatic function. Following a thorough investigation, we diagnosed extensive histiocyte-mediated phagocytosis in many areas (skin, liver, bone marrow), without any identifiable cause. The disease was controlled by immunosuppressive therapy, and the patient remains in complete remission. This case supports the concept of idiopathic generalized histiocyte activation as a distinct entity; this putative disease entity produces massive phagocytosis, regardless of the type of histiocyte differentiation. Similar cases necessitate further study for classification and management.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18192105     DOI: 10.1007/BF02983994

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.319


  11 in total

Review 1.  Macrophage activation syndrome--what's in a name!

Authors:  Athimalaipet V Ramanan; Rayfel Schneider
Journal:  J Rheumatol       Date:  2003-12       Impact factor: 4.666

2.  Hemophagocytic syndrome--should we consider it more often?

Authors:  Ivan Gornik; Vladimir Gasparović
Journal:  Coll Antropol       Date:  2006-12

Review 3.  Contemporary classification of histiocytic disorders. The WHO Committee On Histiocytic/Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte Society.

Authors:  B E Favara; A C Feller; M Pauli; E S Jaffe; L M Weiss; M Arico; P Bucsky; R M Egeler; G Elinder; H Gadner; M Gresik; J I Henter; S Imashuku; G Janka-Schaub; R Jaffe; S Ladisch; C Nezelof; J Pritchard
Journal:  Med Pediatr Oncol       Date:  1997-09

Review 4.  Familial hemophagocytic lymphohistiocytosis. Primary hemophagocytic lymphohistiocytosis.

Authors:  J I Henter; M Aricò; G Elinder; S Imashuku; G Janka
Journal:  Hematol Oncol Clin North Am       Date:  1998-04       Impact factor: 3.722

5.  Histiocytosis syndromes in children. Writing Group of the Histiocyte Society.

Authors: 
Journal:  Lancet       Date:  1987-01-24       Impact factor: 79.321

6.  Macrophage activation syndrome in children with systemic-onset juvenile chronic arthritis.

Authors:  Shinji Kounami; Megumi Yoshiyama; Keiko Nakayama; Masumi Okuda; Shuji Okuda; Noriyuki Aoyagi; Norishige Yoshikawa
Journal:  Acta Haematol       Date:  2005       Impact factor: 2.195

Review 7.  Hematophagic histiocytosis. A report of 23 new patients and a review of the literature.

Authors:  A P Reiner; J L Spivak
Journal:  Medicine (Baltimore)       Date:  1988-11       Impact factor: 1.889

8.  Fulminant hemophagocytic syndrome with a high interferon gamma level diagnosed as macrophage activation syndrome.

Authors:  Tsuyoshi Muta; Yujiro Yamano
Journal:  Int J Hematol       Date:  2004-06       Impact factor: 2.490

9.  The acute lupus hemophagocytic syndrome.

Authors:  K F Wong; P K Hui; J K Chan; Y W Chan; S Y Ha
Journal:  Ann Intern Med       Date:  1991-03-01       Impact factor: 25.391

Review 10.  Hemophagocytic syndromes and infection.

Authors:  D N Fisman
Journal:  Emerg Infect Dis       Date:  2000 Nov-Dec       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.